• Nanoparticle Delivery of PTEN mRNA Reverses Trastuzumab Resi

  2026-04-30

  This study presents a nanoparticle-based platform for systemic delivery of in vitro transcribed PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN function, the approach effectively inhibits the PI3K/Akt pathway, providing a promising strategy for tackling drug resistance in cancer therapy.

• AMPK's Dual Role in Autophagy Regulation Under Energy Stress

  2026-04-30

  This study overturns the canonical model by demonstrating that AMPK inhibits, rather than promotes, ULK1-mediated autophagy initiation during glucose starvation. The findings clarify the nuanced, context-dependent functions of AMPK and reshape how metabolic stress signaling and autophagy are interpreted in eukaryotic cells.

• Naloxone Hydrochloride: Opioid Receptor Antagonist in Resear

  2026-04-29

  Naloxone hydrochloride from APExBIO is redefining opioid receptor antagonist research by enabling precise modulation of opioid signaling in neural, behavioral, and immune assays. Its high purity, solubility, and proven efficacy make it indispensable for experiments probing opioid addiction, withdrawal, and neural stem cell dynamics.

• nor-Binaltorphimine Dihydrochloride in κ-Opioid Receptor Ass

  2026-04-29

  nor-Binaltorphimine dihydrochloride delivers unmatched selectivity for dissecting κ-opioid receptor signaling in experimental pain and addiction research. Recent neural circuit discoveries empower researchers to design more precise, reproducible assays using this antagonist from APExBIO.

• Macromolecular Cryoprotectants Enable High-Fidelity THP-1 Cr

  2026-04-28

  This study demonstrates that macromolecular cryoprotectants, specifically polyampholytes and ice nucleators, significantly improve the post-thaw recovery and differentiation of THP-1 monocytic cells by restricting intracellular ice formation. The findings enable assay-ready immune cell banking and offer critical advances for high-throughput immunology and drug screening workflows.

• 5-Ethynyl-2'-deoxyuridine (5-EdU): Advancing Cell Proliferat

  2026-04-28

  5-Ethynyl-2'-deoxyuridine (5-EdU) streamlines cell proliferation assays with rapid, antibody-free detection, preserving cell morphology in high-throughput workflows. Its click chemistry-based detection enhances sensitivity and flexibility, making it a preferred choice for tumor growth and tissue regeneration studies.

• Protein A/G Magnetic Beads: Precision Tools for Cancer Stem

  2026-04-27

  Explore how Protein A/G Magnetic Beads enable high-fidelity isolation of protein complexes and antibody purification in cancer stem cell research. This article uncovers their unique mechanistic advantages and links cutting-edge translational findings to practical immunoprecipitation workflows.

• cgSHAPE-seq Reveals RNA Degrader Binding Sites in SARS-CoV-2

  2026-04-27

  This study introduces chemical-guided SHAPE sequencing (cgSHAPE-seq), a novel method for mapping small molecule binding sites on structured viral RNAs. Using SARS-CoV-2 as a model, the approach identifies conserved ligand targets in the 5’ UTR and guides the rational design of RNA-degrading chimeras to inhibit viral replication.

• Rottlerin as a PKC Inhibitor: Applied Workflows and Innovati

  2026-04-26

  Rottlerin stands out as a selective PKC inhibitor, empowering precise modulation of apoptosis and cell proliferation in advanced cellular models. This guide translates recent mechanistic and workflow breakthroughs—including clathrin-mediated endocytosis and cytoskeletal targeting—into practical protocols for cancer, virology, and cell biology research.

• Propranolol in Applied Research: Optimizing β-Adrenergic Blo

  2026-04-25

  Propranolol, a non-selective β-adrenergic receptor blocker, unlocks experimental power across cardiovascular, neurobehavioral, and metabolic workflows. Leverage recent mechanistic insights and protocol optimizations for reproducible results in essential tremor therapy, emotional memory modulation, and more.

• Applied Cancer Research with EZ Cap™ Human PTEN mRNA (ψUTP)

  2026-04-24

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore tumor suppressor signaling and overcome resistance in advanced cancer models. This workflow-driven guide translates cutting-edge mRNA delivery strategies into actionable protocols, troubleshooting tips, and comparative insights for robust, reproducible gene expression studies.

• GSK621 (SKU B6020): Optimizing AMPK Agonist Applications in

  2026-04-24

  This article addresses real-world challenges in cell viability and metabolic pathway assays, demonstrating how GSK621 (SKU B6020) delivers robust, reproducible results for acute myeloid leukemia and immunometabolic research. Scenario-driven Q&A blocks clarify best practices, protocol optimization, and vendor selection, with evidence-based guidance tailored for biomedical researchers.

• 25-Hydroxycholesterol-AMPK Axis Shapes Immunosuppressive Mac

  2026-04-23

  Xiao et al. (2024) uncover how 25-hydroxycholesterol accumulation in tumor-associated macrophages activates lysosomal AMPKα via a GPR155–mTORC1 pathway, driving STAT6 phosphorylation and immunosuppressive reprogramming. Targeting this metabolic axis modulates macrophage phenotype and enhances anti-tumor immunity, offering a mechanistic rationale for metabolic intervention strategies.

• Polystyrene Nanoparticles Enhance IR-1061 NIR Imaging for De

  2026-04-23

  The referenced study introduces a method for formulating highly emissive near-infrared (NIR, >1000 nm) fluorescent dye-loaded polystyrene nanoparticles, optimizing their polarity and surface chemistry for robust in vivo deep tissue imaging. By tuning nanoparticle composition and the loading environment, the authors address key limitations of existing organic dyes for biomedical imaging.

• Z-VEID-FMK: Precision Caspase-6 Inhibitor for Apoptosis Assa

  2026-04-22

  Z-VEID-FMK delivers unmatched specificity in dissecting caspase-6-dependent apoptosis, enabling confident analysis in neuronal, immune, and viral infection models. Its robust performance in both standard and advanced workflows makes it the caspase-6 inhibitor of choice for researchers seeking reliable, actionable results.

15461 records 1/1031 page Next 12345 下5页 Last page